Something I don't think I've shared since I learned it about a month ago is the stage of my cancer. For patients who start out with surgery, their cancer is staged at that time due to several things that take place along with breast surgery. Because I went through chemotherapy before surgery, my cancer was not staged until seven months after diagnosis. So during my post-surgery appointment this is what I learned that the chemo had shrunk the tumors significantly, which was very good. But now I'm not quite sure how the staging relates to me, since it is now based on that smaller tumor size. I guess I still have some questions to be answered. But this is what I do know.
My stage is 1A, more accurately described as: Yp, T1a, NO, MX, Group 1A
Yp: signifies staging after chemotherapy, which is considered post neoadjuvant therapy
T represents the size of the tumor. A T1a means Tumor is larger than 1 mm but smaller than 5 mm in greatest dimension
For me, the residual tumor invasive component measures 1.5 mm
N signifies the nodes. NO is node negative, which means there is no cancer in my lymph nodes.
M refers to metastases. MX tells that my cancer has not metastasized and is contained within the breast.
The SBR histologic grade is still III/III.
Based on the microscopic appearance of cancer cells, pathologists commonly describe tumor grade by four degrees of severity: Grades 1, 2, 3, and 4. The cells of Grade 1 tumors resemble normal cells, and tend to grow and multiply slowly. Grade 1 tumors are generally considered the least aggressive in behavior. Conversely, the cells of Grade 3 or Grade 4 tumors do not look like normal cells of the same type. Grade 3 and 4 tumors tend to grow rapidly and spread faster than tumors with a lower grade. The American Joint Committee on Cancer recommends the following guidelines for grading tumors:
Grade
GX Grade cannot be assessed (Undetermined grade)
G1 Well-differentiated (Low grade)
G2 Moderately differentiated (Intermediate grade)
G3 Poorly differentiated (High grade)
G4 Undifferentiated (High grade)
My cancer was 70% Infiltrating ductal carcinoma (IDC), and 30% in situ carcinoma. The "in situ" is new information as of this report. Ductal carcinoma in situ is the earliest possible and most treatable diagnosis of breast cancer. Sounds like its better to have had only 70% be IDC, rather than 100%, so I'll take it. :-)
More good news is that I am no longer TNBC as indicated below. Each test after the original biopsy showed a bit more estrogen receptivity until the MRI biopsy I had late May. During my follow up oncology appointment post surgery I received this information. I am estrogen positive, which means my cancer, or some of it, is receptive to estrogen. So I will follow the radiation with five years of a daily pill of an aromatase inhibitor, most likely a drug known as Femara. This is to prevent recurrence and is something I am scheduled to discuss with my oncologist in a couple of weeks to better understand how this might change my risks.
So this is the latest and greatest from My Journey Past Breast Cancer. I hope that by sharing all this detail I have helped someone to better understand their own diagnosis, or someone else's diagnosis. I know that by putting it together here in this post, I better understand what is going on with me.
Hugs,
Debbie... aka the cancer warrior ... AND SURVIVOR!!!
LIVESTRONG:
I AM STRONG. I AM LOVED. I AM HEALTHY. WE WILL WIN!
Tidak ada komentar:
Posting Komentar